2Ponnazhagan S,Erikson D,Kearns WG,et al.Lack of sitespecific integration of the recombinant adeno-associated virus 2genomes in human cells.Hum Gene Ther,1997,8:275-284.
3Gao GP,Alvira MR,Wang L,et al.Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.Proc Natl Acad Sci USA,2002,99:11854-11859.
4Wang YN,Luk JM,Chung S,et al.In situ gene transfer into rat auxiliary liver transplant.Transplantation,1997,64:1537-1541.
6Grimm D,Kleinschmidt JA.Progress in adeno-associated virus type 2 vector production:promises and prospects for clinical use.Hum Gene Ther,1999,10:2445-2450.
7Duan D,Yue Y,Yan Z,et al.A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation.Nat Med,2000,6:595-598.
8Gao GP,Lu F,Sanmiguel JC,et al.Rep/Cap gene amplification an high-yield production of AAV in an A549 cell line expressing Rep/Cap.Mol Ther,2002,5(5 Pt 1):644-649.
9]Collsco RF,Cao X,Trempe JP.A helper virus-free packaging system for recombinant adeno-associated virus vectors.Gene,1999,238:397-405.
4[1]Su H, Lu RH, Kan YW. Adeno-associated viral vector mediated vasclar endothelial growth factor gene transfer induces neovaccular formation in ischemic heart.Proc NatlAcod Sci USA, 2000, 97 (25): 13 801-806
5[4]Murohara T, Asahara T, Silver M, Bauters C, MasudaH, KalkaC, etal. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest, 1998, 101 (11): 2 567-578
6[5]Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol,1990, 10 (8): 4 239-242
7[6]Harvey BG, Hackett NR, El-Sawy T, Rosengart TK, Hirschowitz EA, Lieberman MD, etal. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol, 1999, 73(8): 6 729-742
8[7]Brizzi MF, Formato L, Bonamini R. The molecular mechanisms of angiogenesis: a newapproach to cardiovascular disease. Ital Heart J, 2001, 2(2): 81-92
9[8]Breier G. Functions of the VEGF/VEGF receptor system in the vascular system.Semin Thromb Hemost, 2000, 26 (5): 553-559
10[10]Behzadian MA, Windsor LJ, Ghaly N, Liou G, Tsai NT, Caldwell RB.VEG F-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J, 2003, 17(6): 752-754
7MC ADA P C,MASON P W,SCHMALJOHN C S,et al.Partial nucleotide sequence of the Japanese encephalitis virus genome[J].Virology,1987,158(2):348-360.
8LIN Y L,CHEN L K,LIAO C L,et al.DNA immunization with Japanese encephalitis virus nonstructural protein NS1elicits protective immunity in mouse[J].J Virol,1998,72(1):191-200.
9XU GY,XU X J,LI Z L,et al.Construction of recombinant pseudorabiesvirus expressing NS1 protein of Japanese encephalitis(SA14-2-14-2-2) virus and its safety and immunogenicity[J].Vaccine,2004,22(15/16):1846-1853.
10FLAMAND M,DEUBEL V,GIRARD M.Expression and secretion of Japanese encephalitis virus nonstructural protein NS1 by insect cells using a recombinant baeulovirus[J].Virology,1992,191(2):826-836.
